Tagged: batu biologics

December 26, 2017 @ 10:06 am By Samantha Hurst  |  

Batu Biologics, an immuno-oncology company focused on the development and commercialization of novel therapies, announced on Monday the closing of its Regulation 506(c) equity crowdfunding offering on EquityNet after successfully securing $1.3 Million in funding. The funding round was launched in May 2017 and was… Read More

January 2, 2015 @ 11:58 am By JD Alois  |  

Batu Biologics wants to eradicate cancer, even in late stage cancer patients.  The company has developed a promising drug called ValloVax that leverages the bodies immune system to recognize the blood cells feeding tumors and cutting them off.  Basically starving cancer and saving the patient.  Earlier… Read More

August 19, 2014 @ 9:55 am By Samantha Hurst  |  

Using a fundraising approach seldom seen in the life sciences sector, Batu Biologics, an immunotherapy company working to develop the first anti-angiogenic cancer vaccine, has successfully raised $100,000 through crowdfunding giant, Indiegogo. Batu Biologics launched the crowdfunding campaign in June 2014 to fund the completion… Read More